CHF does not support the proposed rescheduling of all codeine to Schedule 4 at this point in time. We do not think the delegate has given enough consideration to the significant system wide costs of the rescheduling or the loss of access to a range of medications that do have some benefits to consumers.

Publication type: 
Publish date: 
Friday, October 16, 2015
Consumers Health Forum